Article Menu

Academic Editor

Eytan Mor
Subscribe SciFeed
Recommended Articles
Related Info Links
- PubMed/Medline
- Google Scholar
More by Authors Links

/ajax/scifeed/subscribe

Article Views

Citations -

Printed Edition

A printed edition of this Special Issue is available at MDPI Books....

Altmetric Share Help Cite Discuss in SciProfiles

Need Help?

Support

Find support for a specific problem in the support section of our website.

Get Support

Feedback

Please let us know what you think of our products and services.

Give Feedback

Information

Visit our dedicated information section to learn more about MDPI.

Get Information

Open AccessArticle

Article Versions Notes

J. Clin. Med. 2022, 11(1), 249; https://doi.org/10.3390/jcm11010249

Action	Date	Notes	Link
article xml file uploaded	4 January 2022 12:22 CET	Original file	-
article xml uploaded.	4 January 2022 12:22 CET	Update	https://www.mdpi.com/2077-0383/11/1/249/xml
article pdf uploaded.	4 January 2022 12:22 CET	Version of Record	https://www.mdpi.com/2077-0383/11/1/249/pdf
article html file updated	4 January 2022 12:24 CET	Original file	-
article html file updated	31 July 2022 01:59 CEST	Update	https://www.mdpi.com/2077-0383/11/1/249/html

Cite

Export citation file: BibTeX | EndNote | RIS

MDPI and ACS Style

Imamura, R.; Tanaka, R.; Taniguchi, A.; Nakazawa, S.; Kato, T.; Yamanaka, K.; Namba-Hamano, T.; Kakuta, Y.; Abe, T.; Tsutahara, K.; et al. Everolimus Reduces Cancer Incidence and Improves Patient and Graft Survival Rates after Kidney Transplantation: A Multi-Center Study. J. Clin. Med. 2022, 11, 249. https://doi.org/10.3390/jcm11010249

AMA Style

Imamura R, Tanaka R, Taniguchi A, Nakazawa S, Kato T, Yamanaka K, Namba-Hamano T, Kakuta Y, Abe T, Tsutahara K, et al. Everolimus Reduces Cancer Incidence and Improves Patient and Graft Survival Rates after Kidney Transplantation: A Multi-Center Study. Journal of Clinical Medicine. 2022; 11(1):249. https://doi.org/10.3390/jcm11010249

Chicago/Turabian Style

Imamura, Ryoichi, Ryo Tanaka, Ayumu Taniguchi, Shigeaki Nakazawa, Taigo Kato, Kazuaki Yamanaka, Tomoko Namba-Hamano, Yoichi Kakuta, Toyofumi Abe, Koichi Tsutahara, and et al. 2022. "Everolimus Reduces Cancer Incidence and Improves Patient and Graft Survival Rates after Kidney Transplantation: A Multi-Center Study" Journal of Clinical Medicine 11, no. 1: 249. https://doi.org/10.3390/jcm11010249

APA Style

Imamura, R., Tanaka, R., Taniguchi, A., Nakazawa, S., Kato, T., Yamanaka, K., Namba-Hamano, T., Kakuta, Y., Abe, T., Tsutahara, K., Takao, T., Kishikawa, H., & Nonomura, N. (2022). Everolimus Reduces Cancer Incidence and Improves Patient and Graft Survival Rates after Kidney Transplantation: A Multi-Center Study. Journal of Clinical Medicine, 11(1), 249. https://doi.org/10.3390/jcm11010249

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Printed Edition

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI